Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy

Acta Derm Venereol. 2006;86(3):258-9. doi: 10.2340/00015555-0039.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Adult
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects*
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Facial Dermatoses / chemically induced
  • Facial Dermatoses / diagnosis*
  • Facial Dermatoses / pathology
  • Female
  • Hepatitis C / drug therapy
  • Humans
  • Injections
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / adverse effects*
  • Polyethylene Glycols
  • Recombinant Proteins
  • Ribavirin / administration & dosage
  • Ribavirin / adverse effects*
  • Rosacea / chemically induced
  • Rosacea / diagnosis*
  • Rosacea / pathology

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b